Know What's Happening in BioTech

Liver-Produced Protein Identified as Essential for Men’s Bone Health, New Study Finds
NewsFeb 5, 2026

Liver-Produced Protein Identified as Essential for Men’s Bone Health, New Study Finds

A McGill University study published in Matrix Biology identifies plasma fibronectin, a liver‑produced protein, as a critical regulator of bone formation in male mice. Mice lacking hepatic fibronectin show marked reductions in trabecular bone mass, while female mice are unaffected,...

By Bioengineer.org
Telehealth Provider Hims Goes After Novo's Weight Loss Pill with Compounded Version
NewsFeb 5, 2026

Telehealth Provider Hims Goes After Novo's Weight Loss Pill with Compounded Version

Hims & Hers announced it will begin selling a compounded version of Novo Nordisk's Wegovy weight‑loss injection on Thursday, just weeks after the FDA approved the brand‑name drug. The telehealth firm positions the lower‑cost alternative as a more accessible option...

By Endpoints News
Quantum Computing Speeds up Genome Mapping, Unlocking Faster Disease Diagnosis
BlogFeb 5, 2026

Quantum Computing Speeds up Genome Mapping, Unlocking Faster Disease Diagnosis

Researchers from IIT and IBM have unveiled a hybrid quantum‑classical workflow that accelerates de novo genome assembly by reformulating Hamiltonian and Eulerian path problems as a Higher‑Order Binary Optimisation (HOBO) task solved with the Variational Quantum Eigensolver (VQE). The approach integrates...

By Quantum Zeitgeist
Negatively Charged Carbon Dot‐Linked Glycyrrhizic Acid Hydrogel Promoted Hemostasis, Immunoregulation and Re‐Epithelialization of Wound Closure
NewsFeb 5, 2026

Negatively Charged Carbon Dot‐Linked Glycyrrhizic Acid Hydrogel Promoted Hemostasis, Immunoregulation and Re‐Epithelialization of Wound Closure

The study introduces a charred Trachyparcus‑derived carbon dot (CT‑CD) linked glycyrrhizic acid (GA) hydrogel, termed CT@GA‑gel, that forms at GA concentrations below 0.5 %. The negative surface charge of CT‑CDs enables low‑dose crosslinking, yielding an injectable, self‑healing, and adhesive dressing. Enhanced...

By Small (Wiley)
Eisai Gains Henlius Therapy; LB Pharma Snags $100M in Funding
NewsFeb 5, 2026

Eisai Gains Henlius Therapy; LB Pharma Snags $100M in Funding

Eisai announced an exclusive commercial license with China’s Henlius to sell the anti‑PD‑1 antibody serplulimab in Japan. The agreement gives Eisai sole rights to market the immunotherapy, positioning it alongside the company’s existing oncology portfolio. Serplulimab, a checkpoint inhibitor, is...

By Endpoints News
LimbLab: A Tool to Visualize Embryonic Development in 3D
NewsFeb 5, 2026

LimbLab: A Tool to Visualize Embryonic Development in 3D

LimbLab is an open‑source pipeline created by EMBL Barcelona to visualise and analyse three‑dimensional embryonic limb‑bud data. The workflow cleans raw microscopy volumes, builds computational meshes, assigns developmental age, aligns samples to reference models and logs each step for reproducibility....

By Phys.org – Biotechnology
Solid Foundations Beat AI Hype in Bioinformatics
SocialFeb 5, 2026

Solid Foundations Beat AI Hype in Bioinformatics

1/ AI won’t save sloppy science. Before you dive into deep learning, master your foundations. Here’s why basic bioinformatics still rules 🧵 https://t.co/nPbaEK3hGf

By Ming Tang
The Bioelectric Tech Stack
NewsFeb 5, 2026

The Bioelectric Tech Stack

The episode frames biomanufacturing as a layer of the emerging electric tech stack, arguing that biology will become the chemical manufacturing layer that converts cheap electricity and feedstocks into high‑value molecules. It contrasts China’s systematic investment in the physical infrastructure—feedstock...

By Decoding Bio (Substack)
Prolonged PDA Exposure Raises Late Kidney Injury Risk
NewsFeb 5, 2026

Prolonged PDA Exposure Raises Late Kidney Injury Risk

A multicenter study published in the Journal of Perinatology finds that prolonged exposure to patent ductus arteriosus (PDA) significantly increases the risk of late‑onset acute kidney injury (AKI) in infants born before 28 weeks gestation. Researchers tracked PDA duration and...

By Bioengineer.org
Unveiling the Clinical Significance of Unique Brain Functional Connectomes in Major Depressive Disorder
NewsFeb 5, 2026

Unveiling the Clinical Significance of Unique Brain Functional Connectomes in Major Depressive Disorder

Researchers from Chiba University and partner institutions reported that functional connectome (FC) uniqueness—a measure of individual brain connectivity patterns—is markedly reduced in patients with Major Depressive Disorder (MDD). The study, using harmonized resting‑state fMRI across multiple sites, found the greatest...

By Bioengineer.org
Breakthrough Stem Cell Therapy Shows Promise for Parkinson’s Disease
NewsFeb 5, 2026

Breakthrough Stem Cell Therapy Shows Promise for Parkinson’s Disease

Researchers at USC's Keck Medicine have launched a Phase 1 trial implanting iPSC‑derived dopaminergic neurons to treat moderate‑to‑severe Parkinson's disease. The therapy, using Kenai Therapeutics' RNDP‑001 product, is administered via stereotactic surgery into the basal ganglia of twelve participants. The FDA...

By Bioengineer.org
Revolutionary Low-Temperature Activation Enables Deployment of Smart 4D-Printed Vascular Stents
NewsFeb 5, 2026

Revolutionary Low-Temperature Activation Enables Deployment of Smart 4D-Printed Vascular Stents

Researchers from Japan and China have created a 4D‑printed vascular stent that self‑expands at body temperature, eliminating the need for external heating. The device uses a polycaprolactone‑based shape‑memory polymer composite tuned to a 37 °C transition with diethyl phthalate as a...

By Bioengineer.org
Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy
NewsFeb 5, 2026

Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy

Novartis announced the removal of six Phase 1 oncology candidates—including KFA115, HRO761, MGY825, and AAA802—from its pipeline and introduced two new Phase 1 assets, AMO959 for prostate cancer and GCJ904 for solid tumors. The reshuffle aligns with a strategic review aimed at...

By BioSpace
Commentary Urges Balance Between Research Integrity and Technology Transfer in Biomedicine
NewsFeb 5, 2026

Commentary Urges Balance Between Research Integrity and Technology Transfer in Biomedicine

Virginia Tech professor Robert Gourdie published a commentary in Nature Biotechnology urging policymakers to balance research integrity with a robust technology‑transfer system. He warns that overly restrictive oversight could weaken the U.S. pipeline that moves publicly funded discoveries into commercial therapies....

By Phys.org – Biotechnology
Fluorescent Paper Test Revolutionizes Blood Typing, Antibody Detection
NewsFeb 5, 2026

Fluorescent Paper Test Revolutionizes Blood Typing, Antibody Detection

Researchers have introduced a paper‑based fluorescent assay that uses bioengineered red blood cells stable at room temperature to perform blood typing and antibody titer measurement. The assay combines fluorescent tagging with capillary flow on paper, delivering sensitivity and specificity above...

By Bioengineer.org
Sildenafil’s Variable Impact on Preemie Lung Hypertension
NewsFeb 5, 2026

Sildenafil’s Variable Impact on Preemie Lung Hypertension

A recent multicenter study examined sildenafil’s effectiveness in treating pulmonary hypertension among preterm infants. The findings revealed that while some neonates experienced improved oxygenation and reduced pulmonary pressures, others showed minimal benefit or adverse hemodynamic effects. Efficacy appeared linked to...

By Bioengineer.org
ApexOnco IPO Highlights Valuation Benchmarks for Biotech
SocialFeb 5, 2026

ApexOnco IPO Highlights Valuation Benchmarks for Biotech

$EIKN prices at $18/share, to raise $381m at a $972m market cap. Here's @ApexOnco on what this IPO tells us: https://t.co/OYpmTI21qI

By Jacob Plieth
Programmable RNA 2.0: Beyond the First mRNA Revolution
NewsFeb 5, 2026

Programmable RNA 2.0: Beyond the First mRNA Revolution

BioSpace’s Denatureed podcast episode "Programmable RNA 2.0" spotlights the next wave of RNA therapeutics beyond the COVID‑19 mRNA vaccine success. Host Jennifer Smith‑Parker interviews Erik Digman Wiklund of Circio and Jacob Becraft of Strand Therapeutics about emerging platforms such as circular RNA...

By BioSpace
INBRAIN’s “Rice‑sized” Graphene BCI Chip Marks New Phase in Merck Collaboration
NewsFeb 5, 2026

INBRAIN’s “Rice‑sized” Graphene BCI Chip Marks New Phase in Merck Collaboration

INBRAIN Neuroelectronics announced a new rice-sized graphene BCI chip as part of its ongoing partnership with Merck. The bidirectional chip can record and stimulate neural activity, using AI-driven algorithms to decode speech signals and deliver closed-loop stimulation. Merck is shifting...

By Graphene-Info
A 3D-Printed Delivery System Enhances Vaccine Delivery via Microneedle Array Patch
BlogFeb 5, 2026

A 3D-Printed Delivery System Enhances Vaccine Delivery via Microneedle Array Patch

Researchers at the University of Tokyo used 3D‑printing to add a pillar‑backed layer to microneedle array patches (MAPs), preserving more live virus during fabrication. The pillar‑guided MAPs showed higher viral titers and induced protective immunity against SARS‑CoV‑2 in mice. This...

By Nanowerk
Reviewing Social Determinants in Neonatal Clinical Trials
NewsFeb 5, 2026

Reviewing Social Determinants in Neonatal Clinical Trials

A systematic review in the Journal of Perinatology reveals that neonatal clinical trials largely omit detailed social determinants of health (SDOH) data, with race and ethnicity reported far more often than income, education, or neighborhood factors. The analysis of dozens...

By Bioengineer.org
Grail Multi-Cancer Test Taps Into Hims & Hers Network
NewsFeb 5, 2026

Grail Multi-Cancer Test Taps Into Hims & Hers Network

Grail has partnered with telehealth firm Hims & Hers to sell its Galleri multi‑cancer blood test at a $250 discount off the $949 list price. The collaboration follows Grail’s recent filing for FDA pre‑market approval, based on interim results from...

By pharmaphorum
Connect More
NewsFeb 5, 2026

Connect More

Veeva Systems’ Aaron Bean outlines five connected engagement models for biopharma, from strategic account management to marketing‑centric approaches, to address mounting access challenges in the UK and Europe. He highlights that HCP accessibility in the UK is only 25% versus...

By PharmaTimes
Sex Differences in Atherosclerotic Cardiovascular Disease
BlogFeb 5, 2026

Sex Differences in Atherosclerotic Cardiovascular Disease

A new analysis of the CARDIA cohort spanning 34 years confirms that men experience premature atherosclerotic cardiovascular disease (CVD) several years earlier than women, with a 5% cumulative incidence occurring at age 50.5 versus 57.5 for women. The gap emerges...

By Fight Aging!
Α-Ketoglutarate Interacts with TET to Regulate Cellular Senescence
BlogFeb 5, 2026

Α-Ketoglutarate Interacts with TET to Regulate Cellular Senescence

A recent human trial of α‑ketoglutarate (AKG) supplementation failed to demonstrate measurable health benefits, prompting renewed focus on pre‑clinical evidence. New cell‑based research shows that the AKG‑TET enzymatic axis governs epigenetic reprogramming that drives or reverses cellular senescence. Down‑regulating AKG...

By Fight Aging!
Abbott's Wireless Heart Failure Sensor Cleared for NHS Use
NewsFeb 5, 2026

Abbott's Wireless Heart Failure Sensor Cleared for NHS Use

Abbott’s CardioMEMS HF wireless sensor has received NICE approval for routine NHS use in chronic heart‑failure patients. The tiny implant measures pulmonary artery pressure and transmits daily readings via a pillow‑embedded antenna, allowing clinicians to adjust medication remotely. Clinical trials...

By pharmaphorum
Mitophagy’s Role in Pancreatic Cancer Therapy
NewsFeb 5, 2026

Mitophagy’s Role in Pancreatic Cancer Therapy

Recent research highlights mitophagy—a cellular recycling process—as a promising lever in pancreatic cancer treatment. Activating the PINK1‑PARK2 pathway triggers selective mitochondrial clearance, making tumor cells more vulnerable to chemotherapy and immunotherapy. Pre‑clinical models show that combining mitophagy inducers with standard...

By Bioengineer.org
Peppermint Oil Plasma Coating Could Cut Catheter Infections without Releasing Drugs
NewsFeb 5, 2026

Peppermint Oil Plasma Coating Could Cut Catheter Infections without Releasing Drugs

Researchers at Flinders University have created a nanoscale coating derived from peppermint essential oil using atmospheric‑pressure plasma polymerization. The ultra‑thin film adheres to catheter surfaces, killing E. coli and P. aeruginosa on contact while eliminating up to 90 % of reactive oxygen species...

By Phys.org – Nanotechnology
STAT+: Vertex’s CRISPR Treatment for Sickle Cell Disease Hits Unexpected Roadblock
NewsFeb 5, 2026

STAT+: Vertex’s CRISPR Treatment for Sickle Cell Disease Hits Unexpected Roadblock

Vertex's CRISPR‑based therapy Casgevy, approved over two years ago for sickle cell disease, has treated only about 60 patients globally. The slowdown stems from an unexpected manufacturing hurdle: centers cannot harvest enough autologous cells to produce the drug. This bottleneck...

By STAT (Biotech)
Sanofi Announces the Signing of a Share Buyback Mandate for up to €1 Billion
NewsFeb 5, 2026

Sanofi Announces the Signing of a Share Buyback Mandate for up to €1 Billion

Sanofi disclosed a €1 billion share‑buyback mandate on February 2, 2026, following its January 29 announcement. The program permits the company to repurchase its own shares between February 3 and December 31, 2026. Execution will be managed by an investment‑service provider under the newly signed...

By World Pharma News
Safe and Efficient CRISPR Genome Editing of Primary Human T Cells Using a Droplet‐Based Cell Mechanoporation Platform
NewsFeb 5, 2026

Safe and Efficient CRISPR Genome Editing of Primary Human T Cells Using a Droplet‐Based Cell Mechanoporation Platform

The paper presents a microfluidic droplet mechanoporation platform that delivers macromolecules into primary human T cells with unprecedented efficiency and viability. It achieves ~98% delivery of 2000 kDa FITC‑dextran and ~99% mRNA transfection, enabling robust CAR‑T cell generation. CRISPR‑Cas9 ribonucleoproteins are...

By Small (Wiley)
Bioinspired Dual‐Pathogen Defense Through Electrostatic‐Capturing and Light‐Burst Sterilization for Smart Screen Windows
NewsFeb 5, 2026

Bioinspired Dual‐Pathogen Defense Through Electrostatic‐Capturing and Light‐Burst Sterilization for Smart Screen Windows

Researchers have created an ambient‑light‑activated antimicrobial coating by integrating quaternary ammonium salts (QAS) with aggregation‑induced emission (AIE) photosensitizers onto nonwoven fabrics. The dual‑functional system first electrostatically captures pathogens and then uses light‑burst ROS generation to inactivate them, delivering >99.9% reduction...

By Small (Wiley)
Versatile Chitosan‐Based Hydrogel Dressings for Multi‐Scenario Wound Management
NewsFeb 5, 2026

Versatile Chitosan‐Based Hydrogel Dressings for Multi‐Scenario Wound Management

Researchers have engineered chitosan‑based hydrogel dressings that combine dynamic covalent and non‑covalent cross‑linking to deliver self‑healing, hemostatic, and antimicrobial functions. These smart hydrogels can release therapeutics on demand and respond to pH, temperature, or glucose cues, making them suitable for...

By Small (Wiley)
3 Top Challenges Facing Regulatory Professionals Right Now
NewsFeb 5, 2026

3 Top Challenges Facing Regulatory Professionals Right Now

Regulatory professionals are grappling with three pressing challenges: vague FDA and EMA AI guidance, the mismatch between rapidly evolving AI models and static regulatory frameworks, and a constrained supply chain for radiopharmaceuticals. Experts stress that AI‑driven submissions must rest on...

By BioSpace
Employers Warm Up to Remote Workers Again: BioSpace Report
NewsFeb 5, 2026

Employers Warm Up to Remote Workers Again: BioSpace Report

Biopharma employers are warming to remote hiring again, with 28% saying they will recruit candidates regardless of location in 2026 – up from 20% in 2024 and 16% in 2023. The share of firms focused solely on local talent fell...

By BioSpace
IRF5’s Role in Emphysema via NLRP3 and Ly6C Cells
NewsFeb 5, 2026

IRF5’s Role in Emphysema via NLRP3 and Ly6C Cells

Researchers identified IRF5 as a central driver of emphysema by linking it to heightened NLRP3 inflammasome activity and accumulation of Ly6C‑expressing monocytes in lung tissue. Human samples and mouse models showed elevated IRF5 expression correlating with increased pro‑inflammatory cytokines and...

By Bioengineer.org
Free Halide Ions Enable Switchable Photoluminescence
NewsFeb 5, 2026

Free Halide Ions Enable Switchable Photoluminescence

Researchers have demonstrated that substituting free halide ions in manganese‑based metal halides can reversibly switch photoluminescence intensity and wavelength. The ion‑substitution mechanism alters the local coordination around Mn ions, modulating exciton dynamics and radiative pathways. The switching is repeatable over...

By Bioengineer.org
Leadership’s Impact on Allied Health Professional Identity
NewsFeb 5, 2026

Leadership’s Impact on Allied Health Professional Identity

The 2026 BMC Health Services Research study by Hales, Achour and King investigates how leadership shapes the professional identity of allied health workers. It argues that purpose‑driven mentorship, shared leadership, and values‑based guidance improve job satisfaction, reduce burnout, and enhance...

By Bioengineer.org
Sarepta Saga Has 'Gone on Too Long' As Competitors Catch Up
NewsFeb 5, 2026

Sarepta Saga Has 'Gone on Too Long' As Competitors Catch Up

Sarepta Therapeutics’ one‑time gene therapy Elevidys, priced at $3.2 million, is under intense scrutiny after three patient deaths in 2025 and a steep 80% stock decline. The company’s three‑year efficacy data failed to reassure analysts, and quarterly sales missed expectations, leaving...

By BioSpace
Natto: Unveiling the Surprising Science Behind This Unconventional Superfood
NewsFeb 5, 2026

Natto: Unveiling the Surprising Science Behind This Unconventional Superfood

A study led by Professor Hideshi Ihara at Osaka Metropolitan University discovered that the fermentation of soybeans into natto dramatically increases supersulfide molecules, a class of sulfur metabolites linked to cellular health. The research showed that heat‑treated soybeans further amplify...

By Bioengineer.org
A Groundbreaking Innovation Revolutionizes Medical Device Technology
NewsFeb 5, 2026

A Groundbreaking Innovation Revolutionizes Medical Device Technology

A new medical device merges artificial intelligence with nanoscopic biosensor arrays, enabling real‑time, minimally invasive diagnostics at the cellular level. The integrated AI interprets biomarker signals instantly, delivering results in seconds and supporting continuous monitoring of chronic diseases. Manufacturing leverages...

By Bioengineer.org
AI Foundation Model Aims to Make Stem Cell Therapies More Predictable
NewsFeb 5, 2026

AI Foundation Model Aims to Make Stem Cell Therapies More Predictable

Harvard Medical School researchers have spun out Cellular Intelligence to create a foundation model that predicts stem‑cell behavior and scales production. The company leverages massive high‑throughput capsule experiments to train a machine‑learning system on developmental biology data. By uncovering the...

By Phys.org – Biotechnology
Enhancing Teamwork in Acute Care: A Mixed-Methods Study
NewsFeb 5, 2026

Enhancing Teamwork in Acute Care: A Mixed-Methods Study

A recent mixed‑methods study examined how interdisciplinary teamwork functions in acute‑care settings, combining surveys, observations, and staff interviews. Researchers identified communication gaps, role ambiguity, and workflow bottlenecks that hinder rapid decision‑making. Quantitative data showed a 12% reduction in adverse events...

By Bioengineer.org
Menstrual Blood Testing for HPV Shows Promise as a Reliable Alternative to Cervical Screening
NewsFeb 5, 2026

Menstrual Blood Testing for HPV Shows Promise as a Reliable Alternative to Cervical Screening

A BMJ‑published study of 3,068 Chinese women demonstrates that menstrual‑blood HPV testing matches or exceeds clinician‑collected cervical samples, achieving 94.7% sensitivity for CIN2+ lesions. The method uses a sterile minipad to collect menstrual blood, integrates results via a WeChat‑based app,...

By Bioengineer.org
136 Schools Nationwide Receive Grants to Advance Student and Faculty Health Research
NewsFeb 5, 2026

136 Schools Nationwide Receive Grants to Advance Student and Faculty Health Research

The American Heart Association and the NFL have launched a $350,000 annual grant program, awarding 136 schools across the United States to boost student and faculty health research. The initiative expands the Kids Heart Challenge, American Heart Challenge, and NFL...

By Bioengineer.org
Dialing Out the Hallucinogenic Effect of Psychedelics — BioCentury’s Science Spotlight
NewsFeb 5, 2026

Dialing Out the Hallucinogenic Effect of Psychedelics — BioCentury’s Science Spotlight

Researchers at Sichuan University have identified distinct signaling pathways that separate the hallucinogenic and therapeutic actions of psychedelic compounds. By comparing classic psychedelics with non‑hallucinogenic analogues, they showed that 5‑HT2A‑mediated non‑canonical Gi signaling drives hallucinations, while canonical Gq signaling underlies...

By BioCentury
The Role of Neural Derived Extracellular Vesicles Micro-Ribonucleic Acid Cargo in White Matter Integrity in Early-Onset and Late-Onset Bipolar Disorder
NewsFeb 5, 2026

The Role of Neural Derived Extracellular Vesicles Micro-Ribonucleic Acid Cargo in White Matter Integrity in Early-Onset and Late-Onset Bipolar Disorder

Recent research isolates neural‑derived extracellular vesicles (EVs) from plasma of bipolar disorder patients and maps their micro‑RNA (miRNA) cargo, revealing distinct profiles for early‑onset versus late‑onset cases. Specific miRNAs, such as miR‑211‑5p, miR‑34a and miR‑425‑5p, correlate with diffusion tensor imaging...

By Nature (Biotechnology)
Cutting-Edge Discoveries From MSK Research – February 4, 2026
NewsFeb 4, 2026

Cutting-Edge Discoveries From MSK Research – February 4, 2026

Memorial Sloan Kettering researchers mapped the lineage of rare Thetis immune cells, showing they arise from fetal liver TLP progenitors and depend on RANKL signals during the weaning window. A parallel study revealed that the order of antigen recognition and...

By Bioengineer.org
Asking Amgen to Withdraw Tavneos, FDA Revisits Years-Old Data Issue
NewsFeb 4, 2026

Asking Amgen to Withdraw Tavneos, FDA Revisits Years-Old Data Issue

The FDA has asked Amgen to withdraw its vasculitis drug Tavneos (avacopan) after re‑examining a data‑interpretation issue that was central to the advisory committee’s split vote before its 2021 approval. Amgen, which acquired Tavneos through its $4 billion purchase of ChemoCentryx...

By BioCentury